FDA/GHTF device premarket pilot extended
This article was originally published in The Gray Sheet
Executive Summary
July 6 guidance document says the voluntary program incorporating "Summary Technical Documentation for Demonstrating Conformity" (STED) format for PMA and 510(k) submissions "will remain active until at least June 2005." Under the FDA guidance, which supersedes a June 2003 version, the same four CDRH divisions will participate and additional devices for the pilot still may be requested on a case-by-case basis. In June, Japan committed to accepting device applications in the STED format, originally developed by a Global Harmonization Task Force study group (1"The Gray Sheet" June 21, 2004, p. 27)...
You may also be interested in...
New Japanese Agency Will Accept STED; MHLW Retains Payment Control
Japan's Ministry of Health, Labor & Welfare will accept medical device applications in the STED format beginning next April, according to the U.S. Trade Representative's "1Third Report To The Leaders On The U.S.-Japan Regulatory Reform And Competition Policy Initiative," released June 8
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.